Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of p53 overexpression

Human Pathology

Volumn 30, Issue 7, 1999, Pages 849-855

  Quintanilla Martinez, Leticia ^b   Franklin, Janet L ^b   Guerrero, Ivonne ^b   Krenacs, Laszlo ^b   Naresh, K N ^b   Rama Rao, Clementina ^b   Bhatia, Kishor ^b   Raffeld, Mark ^a   Magrath, Ian T ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

CD56; EBV; Nasal lymphomas; NK T cell; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; NATURAL KILLER CELL LYMPHOMA; NOSE CANCER; NOSE LYMPHOMA; PROTEIN EXPRESSION; T CELL LYMPHOMA;

EID: 0032800452     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90147-8     Document Type: Article

References (40)

1. Arber DA, Weiss LM, Albújar PF, et al: Nasal lymphomas in Peru: High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17:392-399, 1993
2. Misad O, Solidoro A, Quiroz L, et al: An overview of lymphoreticular malignancies in Peru. Prog Cancer Res Ther 27:85-97, 1984
3. Frierson HF, Mills SE, Innes DJ: Non-Hodgkin's lymphomas of the sinonasal region: Histologic subtypes and their clinicopathologic features. Am J Clin Pathol 81:721-727, 1984
4. Ng CS, Chan JKC LS, Poon YF: Immunophenotypic analysis of non-Hodgkin's lymphomas in Chinese: A study of 75 cases in Hong Kong. Pathology 18:419-425, 1986
5. Ho FCS, Todd D, Loke SL, et al: Clinicopathological features of malignant lymphomas in 294 Hong Kong Chinese patients: Retrospective study covering an eight year period. Int J Cancer 34:143-148, 1984
6. Aozasa K, Ohsawa M, Tajima K, et al: Nation-wide study of lethal mid-line granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 44:63-66, 1989
7. Kanavaros P, Lescs M-C, Briere J, et al: Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81:2688-2695, 1993
8. Chan JKC, Yip TTC, Tsang WYW, et al: Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am J Surg Pathol 18:938-946, 1994
9. Jaffe ES, Chan JKC, Su I-J, et al: Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20:103-111, 1996
10. Ng CS, Chan JKC, Lo STH: Expression of natural killer cell markers in non-Hodgkin's lymphomas. HUM PATHOL 18:1257-1262, 1987
11. Tsang WYW, Chan JKC, Ng CS, et al: Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas. Am J Surg Pathol 20:202-210, 1996
12. Gutiérrez MI, Spangler G, Kingma D, et al: Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. Blood 92:600-606, 1998
13. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
14. Chiang AKS, Chan ACL, Srivastava G, et al: Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer 73:332-338, 1997
15. Chiang AKS, Tao Q, Srivastava G, et al: Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 68:285-290, 1996
16. Chiang AKS, Srivastava G, Lau PWF, et al: Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: Implications on cellular origin. HUM PATHOL 27:701-707, 1996
17. Van Gorp J, Weiping L, Jacobse K, et al: Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China. J Pathol 173:81-87, 1994
18. Chan JKC, Ng CS, Lau WH, et al: Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 11:418-429, 1987
19. Tsang WYW, Chan JKC, Yip TTC, et al: In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphoma. HUM PATHOL 25:758-765, 1994
20. Chan JKC, Sin VC, Wong KF, et al: Nonnasal lymphomas expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89:4501-4513, 1997
21. Weiss LM, Gaffey MJ, Chen YY, et al: Frequency of Epstein-Barr viral DNA in "Western" sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am J Surg Pathol 16:156-162, 1992
22. Elenitoba-Johnnson KSJ, Zarate-Osorno A, Meneses A, et al: Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 11:754-761, 1998
23. van de Rijn M, Bhargava V, Molina-Kirsch H, et al: Extranodal head and neck lymphomas in Guatemala. HUM PATHOL 28:834-839, 1997
24. Anderson P, Nagler-Anderson C, O'Brien C, et al: A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 144:574-582, 1990
25. Anderson P: TIA-1: Structure and functional studies on a new class of cytolytic effector molecule. Curr Top Microbiol Immunol 198:131-143, 1995
26. Emile JF, Boulland ML, Haioun C, et al: CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87:1466-1472, 1996
27. Mori N, Tatabe Y, Oka K, et al: Expression of perforin in nasal lymphoma: Additional evidence of its natural killer cell derivation. Am J Pathol 149:699-705, 1996
28. Krenacs L, Wellmann A, Sorbara L, et al: Cytotoxic cell antigen expression in anaplastic large cell lymphoma of T- and null-cell type and Hodgkin's disease: Evidence for distinct cellular origin. Blood 89:980-989, 1997
29. Ng C-S, Lo STH, Chan JKC, et al: CD56+ putative natural killer cell lymphomas: Production of cytolytic effectors and related proteins mediating tumor cell apoptosis? HUM PATHOL 28:1276-1282, 1997
30. Cheng RZ, Guan XY, Lau G, et al: Chromosome 1p terminal deletion and loss of chromosome 17p and 16p are common findings in nasal NK/T cell lymphoma by comparative genomic hybridization. Mod Pathol 11:126A, 1998
31. Chen WG, Chen YY, Kamel OW, et al: p53 mutations in Hodgkin's disease. Lab Invest 75:519-527, 1996
32. Elenitoba-Johnson KS, Medeiros LJ, Khorsand J, et al: P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease. Am J Clin Pathol 106:728-738, 1996
33. Matsushima AY, Knowles DM, Chadburn A, et al: Post-thymic T-cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. Am J Pathol 144:573-584, 1994
34. Gulley ML, Burton MP, Allred DC, et al: Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. HUM PATHOL 29:252-259, 1998
35. Chen W, Cooper NR: Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kB. J Virol 70:4849-4853, 1996
36. Szekely L, Pokrovskaja K, Jiang W-Q, et al: Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns. Oncogene 10:1869-1874, 1995
37. Nakamura S, Koshikawa T, Yatabe Y, et al: Lymphoblastic lymphoma expressing CD56 and TdT (Letter to the editor). Am J Surg Pathol 22:135-137, 1998
38. Koita H, Suzumiya J, Ohshima K, et al: Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am J Surg Pathol 21:242-248, 1997
39. DiGiuseppe JA, Louie DC, Williams JE, et al: Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study. Am J Surg Pathol 21:1223-1230, 1997
40. Scott AA, Head DR, Kopecky KJ, et al: HLA-DR-CD33+-CD56+CD16- myeloid/NK cell leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 84:244-256, 1994